Black Diamond Therapeutics to Present at Investor Conferences
ByAinvest
Monday, Mar 2, 2026 4:03 pm ET1min read
BDTX--
Black Diamond Therapeutics, a clinical-stage oncology company, will participate in the 46th Annual TD Cowen Healthcare Conference and the 25th Annual Needham Virtual Healthcare Conference. The company's President and CEO, Mark Velleca, and Chief Scientific Officer, Elizabeth Buck, will present at the conferences. The presentations will be webcast on the company's website and available for 90 days. Black Diamond is developing MasterKey therapies that target families of oncogenic mutations in patients with cancer.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue



Comments
No comments yet